Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_assertion type Assertion NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_head.
- NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_assertion wasGeneratedBy ECO_0000203 NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_provenance.
- NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_assertion wasDerivedFrom befree-20140225 NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_provenance.
- NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_assertion SIO_000772 20805990 NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_provenance.
- NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_assertion evidence source_evidence_literature NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_provenance.
- NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_provenance.